Analyst Andrew Baum works at CITI and is covering the the Healthcare sector with 106 price targets and ratings documented since 2013 spanning on 11 stocks.
Andrew Baum's average stock forecast success ratio is 64.95% with an average time for price targets to be met of 366 days.
Most recent stock forecast was given on MRK, Merck & Co., Inc at 13-Apr-2023.
Analyst best performing recommendations are on LLY (ELI LILLY AND COMPANY).
The best stock recommendation documented was for LLY (ELI LILLY AND COMPANY) at 10/1/2021. The price target of $265 was fulfilled within 34 days with a profit of $39.93 (17.74%) receiving and performance score of 5.22.
Average potential price target upside
Currently, out of the existing stock ratings of Andrew Baum - 3 which are a Hold (75%), 1 which are a Buy (25%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Buy
181
$43.04 (31.20%)
178
1 months 22 days ago
6/14 (42.86%)
$27.73 (32.87%)
467
Buy
155
1 months 27 days ago
1/1 (100%)
$21 (15.67%)
90
Buy
172
$34.04 (24.67%)
166
3 months ago
23/24 (95.83%)
$22.65 (31.91%)
519
Hold
127
3 months 10 days ago
1/1 (100%)
$21.13 (19.96%)
240
Sell
153
$15.04 (10.90%)
135
3 months 22 days ago
20/20 (100%)
$20.08 (31.50%)
519
